Top Markets
Coin of the day
H-CYTE, Inc. H-CYTE, Inc.

H-CYTE, Inc.

HCYT
Rang in aandelen #39155
H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated... H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated to developing and supplying a range of treatments for individuals afflicted with persistent respiratory and pulmonary diseases. The company's core strategy involves pioneering and deploying autologous cellular therapy solutions specifically for chronic lung conditions. Additionally, H-CYTE maintains a product supply agreement with Rion, LLC, focused on advancing and distributing a biologic compound designed to combat chronic obstructive pulmonary disease (COPD). Its corporate headquarters are situated in Tampa, Florida.
Aandeelprijs
$0.995
Laatst gesynchroniseerd: 2023-07-07
Marktkapitalisatie
$624.98K
Verandering (1 dag)
-0.50%
Verandering (1 jaar)
0.00%
Land
US
Handel H-CYTE, Inc. (HCYT)

Categorie

Dividendrendementgeschiedenis voor H-CYTE, Inc. (HCYT)
Het dividendrendement (TTM) van H-CYTE, Inc. (aandelsymbool: HCYT) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van H-CYTE, Inc. (HCYT) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten